Walgreens' Pessina estimates that the combined company will have to sell roughly 500 stores in order to gain regulatory approval from the FTC. » Read More
The U.S. consumer has grown remarkably resilient, according to a new report. Two key sectors are driving the spending.
Shares of Rite Aid spiked Friday after the New York Post reported Walgreens is continuing talks with the FTC about approving a merger.
Jim Cramer explained how the “Pokemon Go” craze is stemming from changes in the technological landscape.
Amazon sellers have long dealt with counterfeiters, but with Chinese goods flooding the marketplace the problem is exploding.
The "FMHR" traders reveal their final trades.
Jim Cramer will be ready for stocks to make a bang next week when this number is reported.
Theranos still has yet to take advantage of the Cleveland Clinic's offer to test its blood diagnostic technology, says Dr. Toby Cosgrove.
As online viewers grow up, they're looking for digital shows that suit their needs. And this is also changing advertising as we know it.
Jim Cramer says the government has caused too much supply in the market, which will result in bad news for stocks with no end in sight.
The media wanted to believe in Theranos, but the blood-testing start-up has always been a "scam," Sam Waksal said.
Pharmacy reimbursement rates challenged Rite Aid earnings in the latest quarter, Chairman and CEO John Standley said, in a statement.
Take a look at some of Thursday's early movers: YHOO, M, RAD, CTRP, WMT, JBL
Jim Cramer deconstructs the core assets of Valeant, and found the most troubled part of a very troubled company.
Check out the companies making headlines after the bell Monday: Baidu, Square, Intuit and more.
LinkedIn, Apple, Yahoo and Walgreens are making headlines this Monday morning.
Take a look at some of Monday's early movers: AAPL, WBA, T, VZ, YHOO, VRX, SYMC
The drugstore chain will stop offering the blood-testing company's services at its stores.
Walgreens says it will close all 40 Theranos Wellness Centers and will no longer offer any Theranos services at any of its stores.
Shares of Walgreens and Rite Aid skyrocketed around 4 percent amid reports that the FTC is likely to approve Walgreens' acquisition of Rite Aid.
Valeant is attempting to restructure a deal with Walgreens after warning it is losing money on medicines, reported the Financial Times.